“Identification Of A Potential Susceptibility Locus For Macular Telangiectasia Type 2.”. Plos One 7 (8). Plos One: e24268. doi:10.1371/journal.pone.0024268.
. 2012. “Preliminary Assessment Of Celecoxib And Microdiode Pulse Laser Treatment Of Diabetic Macular Edema.”. Retina 30 (3). Retina: 459-67. doi:10.1097/IAE.0b013e3181bcf1a0.
. 2010. “Score Study Report 1: Baseline Associations Between Central Retinal Thickness And Visual Acuity In Patients With Retinal Vein Occlusion.”. Ophthalmology 116 (3). Ophthalmology: 504-12. doi:10.1016/j.ophtha.2008.10.017.
. 2009. “Score Study Report 3: Study Design And Baseline Characteristics.”. Ophthalmology 116 (9). Ophthalmology: 1770-1777.e1. doi:10.1016/j.ophtha.2009.03.022.
. 2009. “The National Eye Institute Visual Function Questionnaire In The Macular Telangiectasia (Mactel) Project.”. Invest Ophthalmol Vis Sci 49 (10). Invest Ophthalmol Vis Sci: 4340-6. doi:10.1167/iovs.08-1749.
. 2008.